Biotech · Private company · Seattle, WA, US
Epicure Therapeutics, Inc.
Track this companyFree. Adds Epicure Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards1
- Cell class-specific AAV gene therapy for SLC6A1-related neurodevelopmental disorderFiscal year 2026 · $1.5MNIH RePORTER 1R44NS145930-01A1 · fetched Nov 12, 2026